<DOC>
	<DOCNO>NCT02501109</DOCNO>
	<brief_summary>The purpose study compare rate extent absorption Aripiprazole Oral Soluble Film 10 mg ( Test ) versus Abilify® 10 mg tablet ( Reference ) healthy male volunteer</brief_summary>
	<brief_title>Comparative Bioavailability Study Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet Healthy Volunteers</brief_title>
	<detailed_description>The propose study single centre , bioavailability , open-label , randomize , single-dose , 3-period , 6-sequence , crossover study fast condition . Each volunteer give single dose Test formulation two study period ( without water ) , single dose Reference formulation ( water ) study period .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Male female , moderate smoker ( 9 cigarette daily ) nonsmoker , ≥45 ≤65 year age , BMI &gt; 18.5 &lt; 30.0 kg/m2 body weight 50.0 kg male 45.0 kg female . 2 . Healthy define : 3 . Females childbearing potential sexually active male partner must willing use one follow acceptable contraceptive method throughout study 42 day last study drug administration : 4 . Capable consent . 1 . Any clinically significant abnormality abnormal laboratory test result find medical screening positive test hepatitis B , hepatitis C , HIV find medical screening . 2 . Positive urine drug screen screen . 3 . History allergic reaction aripiprazole , dimenhydrinate , benztropine , diphenhydramine relate drug . 4 . Use drug know induce inhibit hepatic drug metabolism within 30 day prior first study drug administration . 5 . Positive pregnancy test screening . 6 . Any reason , opinion Medical SubInvestigator , would prevent subject participate study . 7 . Clinically significant electrocardiogram ( ECG ) abnormalities vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90 mmHg , heart rate less 50 100 bpm ) , decrease systolic blood pressure 20 mmHg high , decrease diastolic blood pressure 10 mmHg high within 2 3 minute pass supine stand position , screen . 8 . History significant alcohol abuse within one year prior screen regular use alcohol within six month prior screen visit ( fourteen unit alcohol per week [ 1 Unit = 150 mL wine , 360 mL beer , 45 mL 40 % alcohol ] ) . 9 . History significant drug abuse within one year prior screen use soft drug ( marijuana ) within 3 month prior screen visit hard drug ( cocaine , phencyclidine ( PCP ) , crack ) within 1 year prior screen . 10 . Use aripiprazole medical condition context another clinical trial within period 42 day prior first dosing . 11 . Participation clinical trial involve administration investigational market drug within 30 day ( 90 day biologics ) prior first dose concomitant participation investigational study involve drug administration . 12 . Use medication topical product without significant systemic absorption hormonal contraceptive : prescription medication within 14 day prior first dosing ; overthecounter product include natural health product ( e.g . food supplement herbal supplement ) within 7 day prior first dosing , exception occasional use acetaminophen ( 2 g daily ) ; depot injection implant drug ( hormonal contraceptive ) within 3 month prior first dose . 13 . Donation plasma within 7 day prior dose . Donation loss blood ( exclude volume drawn screen ) 50 mL 499 mL blood within 30 day , 499 mL within 56 day prior first dosing . 14 . Hemoglobin &lt; 128 g/L ( male ) &lt; 115 g/L ( female ) hematocrit &lt; 0.37 L/L ( male ) &lt; 0.32 L/L ( female ) screen . 15 . Breastfeeding subject . 16 . HAMD7 scale score 3 screening .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Oral Soluble Film</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>